Mean fasting plasma glucose concentration decreased over the study period with vildagliptin vs placebo by -@ mmol/L ( P = @ ) , and there was a positive correlation between these decrements and liver triglyceride in the vildagliptin group at @ months ( r = @ ; P = @ ) and @ months ( r = @ ; P = @ ) .